Gounder, M., Johnson, M., Heist, R. S., Shapiro, G. I., Postel-Vinay, S., Wilson, F. H., . . . Tabernero, J. MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: A phase I trial. Nature Portfolio.
Chicago Style (17th ed.) CitationGounder, Mrinal, et al. MAT2A Inhibitor AG-270/S095033 in Patients with Advanced Malignancies: A Phase I Trial. Nature Portfolio.
MLA (9th ed.) CitationGounder, Mrinal, et al. MAT2A Inhibitor AG-270/S095033 in Patients with Advanced Malignancies: A Phase I Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.